A diversified healthcare large with progress alternatives
Johnson & Johnson (NYSE: JNJ) is a $400 billion healthcare firm that sells shopper items, branded pharmaceuticals, and medical gadgets. Manufacturers reminiscent of Band-Assist, Listerine, and Tylenol, together with different frequent dwelling care and beauty merchandise, are predictable companies with comparatively secure demand throughout financial cycles.
J&J’s pharmaceutical phase has quite a few blockbusters and a sturdy pipeline throughout a number of classes, together with immunology, infectious illness, oncology, neuroscience, and cardiovascular. Well-liked medicine reminiscent of Stelara, Imbruvica, Darzalex, and Remicade drive annual gross sales above $40 billion and have helped the corporate maintain vast revenue margins.
The corporate’s medical gadget phase provides orthopedic, surgical, and imaginative and prescient merchandise that generate greater than $20 billion in annual gross sales. This can be a aggressive business that can be extra delicate to financial situations, however Johnson & Johnson continues to be one of many international gadget market leaders that may proceed to develop in the long run.